BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1864717)

  • 21. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
    Hübler J; Szántó A; Könyves K
    Int Urol Nephrol; 2003; 35(4):519-21. PubMed ID: 15198160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
    Shamloul R; Atteya A; Elnashaar A; Gadallah A; Zohdy W; Abdelsalam W
    J Sex Med; 2005 Jan; 2(1):117-20. PubMed ID: 16422914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence and management of priapism in Western Australia: a 16 year audit.
    Earle CM; Stuckey BG; Ching HL; Wisniewski ZS
    Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism.
    Vapnek J; Lue TF
    J Urol; 1989 Nov; 142(5):1323-4. PubMed ID: 2509734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-induced priapism--a report of experiences in 101 cases].
    Porst H; van Ahlen H
    Urologe A; 1989 Mar; 28(2):84-7. PubMed ID: 2718298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 28. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Are intracavernous injections of drugs for impotence harmless?].
    Bondil P
    Acta Urol Belg; 1988; 56(2):202-10. PubMed ID: 3400526
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
    Schrey A
    Fortschr Med; 1990 Oct; 108(30):577-80. PubMed ID: 2245960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complications of intracavernous pharmacologic infusion in impotence. Long-term results].
    Pastorini S; Marino G; Cocimano V; Griffa D; Pugno E
    Minerva Urol Nefrol; 1993 Sep; 45(3):109-12. PubMed ID: 8278876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for papaverine-induced priapism.
    Lomas GM; Jarow JP
    J Urol; 1992 May; 147(5):1280-1. PubMed ID: 1569668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Priapism of low flow].
    Ruiz Cerda JL; Moreno Pardo B; Server Pastor G; Osca García JM; Vera Donoso C; Jiménez Cruz JF
    Actas Urol Esp; 1991; 15(6):510-4. PubMed ID: 1792989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracorporeal phenylephrine in the treatment of priapism.
    Muruve N; Hosking DH
    J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of pharmacological priapism with phenylephrine.
    Dittrich A; Albrecht K; Bar-Moshe O; Vandendris M
    J Urol; 1991 Aug; 146(2):323-4. PubMed ID: 1856926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comment on the contribution by H. Porst and H. van Ahlen. Drug-induced priapism--a report of experiences with 101 cases. Urologe [A] (1989) 28: 84-7].
    Rudnick J
    Urologe A; 1989 Nov; 28(6):367. PubMed ID: 2603283
    [No Abstract]   [Full Text] [Related]  

  • 38. [Priapism as a complication following diagnostic papaverine test].
    Darewicz J; Galek L
    Z Urol Nephrol; 1989 Jun; 82(6):317-9. PubMed ID: 2763728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
    Kulmala RV; Tamella TL
    Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.